Myeloid Sarcoma in the Sinonasal Cavity with Orbital Involvement: A Case Report

Dianli Fitriani, Krisna Murti, Eriza Eriza

Abstract


Introduction: Myeloid sarcoma (MS) is a tumor mass that arises outside of the bone marrow area and is composed of either mature or not myeloid blasts of white blood cells. Acute myeloid leukemia (AML), chronic myeloid leukemia (CML) with an imminent blast crisis, and other underlying undiagnosed myeloproliferative disorders are frequently linked to MS, an uncommon disease. Without a history of leukemia, MS is difficult to diagnose and might be misdiagnosed for lymphoma or undifferentiated carcinoma. For patients, correct tissue diagnosis based on immunohistochemistry and histomorphology is important.

Case Presentation: Here, we present a 27-year-old woman who had a surgical procedure in The Department of Otorhinolaryngology-Head and Neck Surgery with the chief complaint of right nasal congestion and growing right eye protrusion. A solid mass in the right sinonasal region with infiltration into the retrobulbar area was confirmed by a head computed tomography (CT) scan. Cells with small to medium-sized cells, finely distributed chromatin, tiny nucleoli, and sparse cytoplasm were examined under a microscope. These cells were grouped in diffuse, linear, or Indian file patterns. Microscopic examination revealed morphology of myeloid tumor. Immunohistochemistry analysis emphasized the diagnosis of myeloid sarcoma. The patient then had chemotherapy, comprising of six cycles of docetaxel and carboplatin. After completing chemotherapy, a reduction in the size of the tumor mass was observed.

Conclusions: MS was diagnosed based on histological, radiographic, and immunohistochemical studies. Additional immunohistochemistry analysis testing is necessary to rule out a number of differential diagnoses when diagnosing MS in patients without a history of leukemia or hematological malignancy. The positive expression of myeloid markers such as CD68, CD15, CD33, and CD34 supports a diagnosis of MS.


Keywords


myeloid sarcoma, sinonasal neoplasm, sinonasal mass

Full Text: View | Download

DOI: 10.33371/ijoc.v18i4.1185

Article Metrics

Abstract View: 134,
PDF Download: 108
             

References


S.A Pileri, A Orazi, B Falini. Myeloid sarcoma in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.4th ed. Lyon: IARCH; 2017.p 167-68.

AlSemari MA, Perrotta M, Russo C, et al. Orbital myeloid sarcoma (chloroma): Report of 2 cases and literature review. Am J Ophthalmol Case Reports. 2020;19:100806.

Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Myeloid Sarcoma. Oncol Res Treat. 2019;42(4):219-24.

Bhaskar K. Myeloid Sarcoma: The Other Side of Acute Leukemia. Intech. 2016;11(tourism):13. Avalilable from: https://www.intechopen.com/books/advanced-biometric-technologies/liveness-detection-in-biometrics

Shahin OA, Ravandi F. Myeloid sarcoma. Curr Opin Hematol. 2020;27(2):88-94.

Wang HQ, Li J. Clinicopathological features of myeloid sarcoma: Report of 39 cases and literature review. Pathol Res Pract. 2016;212(9):817-24.

Coltro G, Mannelli F, Vergoni F, et al. Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature. Clin Exp Med. 2020;20(2):313-20.

Cantone E, Cavaliere M, Di Lullo AM, Guadagno E, Iengo M. Immunohistochemical patterns in the differential diagnosis of rhinopharyngeal granulocytic sarcoma. Oncol Lett. 2016;12(4):2777-81.

Kaushik N, Kumar L, Agarwal P, Kumar H, Sharma B. Monoblastic Sarcoma- A Rare Case Report of Myeloid Sarcoma Variant. J Clin Diagnostic Res. 2021;15(6):15-17.

Zhao H, Dong Z, Wan D, et al. Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma. Sci Rep. 2022;12(1):1-10.

Athukuri P, Khan A Basit, Gadot Ron, Monira H, Lee Sungho, Gallagher K, et al. Myeloid sarcoma of the skull base: A case report and systematic literature review Prazwal. Surg Neurol Int. 2022;13(510).


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.